INDBInternet News Database 2.5 Updated 1 min ago · 374 sources Show or hide images Light or dark

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

Save Like Comments Compare coverage

Summary

Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

Description from CNBC.

Who is covering this

  1. CNBC Center Factuality: High US
    Novo says Wegovy injection lowers BMI and obesity rates in children in trial

    Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

Comments

Comments need JavaScript.